Saturday May 18
Applied Clinical Trials
Takeda And Lundbeck Present Results From Pivotal Phase 3 Clinical...
These data will be presented at the 2013 American Psychiatric Association Annual Meeting in The objective of these four studies was to evaluate the efficacy and safety profile of vortioxetine in doses ranging from 10-20 mg per day, complementing other studies in the New Drug Application submission package that included dose ranges of 5-20 mg per ... (more)
Infection Control Today
Rough U.S. Flu Season Boosts Numbers for Tamiflu
Drugs.com, a leading online clinical drug resource, today released first quarter 2013 U.S. prescription sales data for the top 100 drugs.
Supplement builds strength in fibromyalgia trial
Apart from helping with muscle weakness, though, the treatment had little effect on other symptoms of the mysterious disorder, such as chronic pain, fatigue, memory loss, depression, anxiety and sleeplessness.
The Indianapolis Star
Eli Lilly and Co. settles wrongful death lawsuit
Eli Lilly and Co. has settled a long-running wrongful death lawsuit filed by the parents of a South Dakota boy who committed suicide on Christmas Eve 2004, four weeks after taking the antidepressant Cymbalta.